Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For CSGS
Valuation Somewhat Positive
56%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
33%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 13.33 1.74 1.54
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 18.67 9.21 7.76
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -1.14 9.45 9.55
Cash -67.47 4.24 13.02
Capex 4.92 -0.17 -0.18
Free Cash Flow -54.04 -1.20 2.60
Revenue -0.42 10.35 10.39
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -1.89 0.45 0.45
Operating Margin 2.42 0.11 0.11
ROA 71.48 0.02 < 0.005
ROE 55.92 0.07 0.05
ROIC -3.56 0.03 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of CSGS is permitted for members.
5 Growth
The "Growth Entry" for the Focus of CSGS is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of CSGS is permitted for members.